November 2025 Investment Update
Staying the Course Amid Shifting Momentum
October continued the market’s upward trajectory, rewarding investors who maintained discipline through a year of volatility. U.S. equities posted another month of solid gains, with technology and healthcare leading the charge. The S&P 500 and Nasdaq Composite both extended their positive momentum, while small-caps regained footing after uneven performance earlier in the year.
Our investment team maintained existing allocations with one key change, we have sold our position in Materials, reallocating that exposure back into our core holdings. We continue to hold allocations to Healthcare and Biotech, sectors that remain supported by strong innovation trends, attractive valuations, and steady demand through various economic environments.
Market Recap
October’s results demonstrated broad participation across major indices, bolstered by resilient consumer spending, easing inflation expectations, and a strong earnings season from large-cap technology companies.
(Source: MarketWatch, Yahoo Finance, October 31 2025)
Equities benefited from broad risk-on sentiment as investors interpreted the Federal Reserve’s latest statements as a signal of a measured rate-cutting environment. While fixed income posted modest gains, credit spreads remained tight, and investors continued to favor equity exposure for long-term growth potential.
Contributing Factors
Several themes shaped market direction in October:
Federal Reserve Outlook
Markets responded favorably to signs that the Fed is comfortable with the pace of inflation moderation. Although policymakers maintained a cautious tone, October’s data showed continued progress toward the Fed’s 2% target. The market now expects an additional rate cut in early 2026 if current trends persist.
Earnings and Corporate Resilience
Third-quarter earnings season exceeded expectations across multiple sectors, with mega-cap technology, healthcare, and industrial firms posting strong results. Profit margins proved more durable than anticipated, supporting investor confidence.
Sector Leadership
Technology and healthcare continued to outperform, while energy and materials lagged amid mixed commodity prices. This divergence reinforces the benefit of maintaining diversified exposure and rotating toward areas of structural strength, a principle that continues to guide our positioning.
Portfolio Positioning: Discipline and Adaptation
Our disciplined approach remains intact. In October, we maintained all asset allocations except for the sale of our Materials exposure, reallocating proceeds into our core diversified equity holdings. This change reflects our conviction that core equities offer broader participation in market gains while still maintaining exposure to the strongest sectors.
Core Allocations - No Change
- Diversified large-cap U.S. equities
- Small-cap U.S. equities
- Fixed income aligned with your risk profile
Areas of Emphasis
Continued focus in Healthcare and Biotech.
These areas continue to present long-term growth potential supported by innovation, demographic trends, and consistent earnings growth.
Note: Asset allocation and diversification do not guarantee a profit or protect against loss in declining markets. All investments involve risk, including the potential loss of principal.
Looking Ahead
As we move into the final weeks of 2025, markets are focused on three critical crosscurrents:
1. The Fed’s Policy Path: With inflation cooling and growth stabilizing, attention will turn to how the Fed balances rate cuts with long-term inflation control. We remain vigilant for signs of policy missteps or unexpected data that could impact sentiment.
2. Year-End Earnings and Seasonal Trends: Historically, November and December have been constructive months for equities, particularly when markets enter Q4 with strong momentum. We expect volatility to persist but see opportunities for disciplined investors.
3. Sector Rotation Potential: The divergence between technology and cyclical sectors may create opportunities in select areas as valuations normalize. Our focus remains on maintaining flexibility and following data-driven signals of strength.
A Final Note
As always, your financial goals remain our priority. Our team continues to evaluate markets with care, adapting when necessary but never reacting emotionally to short-term noise. If you’d like to review your portfolio or discuss positioning for the new year, please reach out to your advisor.
We appreciate your trust and partnership as we help you navigate the months ahead with clarity, confidence, and purpose.
Important Disclosures
This communication is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Strategic Advisory Partners (“SAP”) is a registered investment advisor. Registration does not imply a certain level of skill or training.
Past performance is not indicative of future results. No investment strategy, including trend following, can guarantee profits or protect against losses. Market indices mentioned are unmanaged and cannot be invested in directly. Index performance does not reflect transaction costs, fees, or expenses.
Forward-looking statements, including projections of market performance, earnings growth, Federal Reserve actions, and economic conditions, are based on various assumptions and beliefs that may not prove to be accurate. These statements should not be relied upon for making investment decisions.
Investment decisions should be based on an individual’s own goals, time horizon, and risk tolerance. Diversification and asset allocation do not ensure a profit or protect against loss.
This material has been prepared from sources believed to be reliable but is not guaranteed as to accuracy or completeness. This information may change at any time based on market or other conditions.
©2025 Strategic Advisory Partners. All rights reserved.
